Hormone replacement therapy for menopausal women

Comprehensive Therapy

Volumn 26, Issue 3, 2000, Pages 197-202

  Moghissi, K S ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; RALOXIFENE;

ARTICLE; CLINICAL TRIAL; COLON CANCER; DEMENTIA; DEPRESSION; ENDOMETRIUM HYPERPLASIA; FEMALE; FLUID RETENTION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; NAUSEA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RISK ASSESSMENT;

EID: 0033844144     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-000-0009-6     Document Type: Article

References (20)

1. Comparison of ligand binding specificity and transcript distribution of estrogen receptors α and β
2. Effects of natural oestrogen replacement therapy on menopausal symptoms and blood clotting
3. Hot flushes
4. Meta-analysis of estrogen therapy in management of urogenital atrophy in postmenopausal women: Second report on the Hormone and Urogenital Therapy Committee
5. Effects of hormone therapy on bone mineral density
6. Estrogen: Prevention and treatment of osteoporosis
7. Effect of estrogen or estrogen/progestin regimens on breast change: Risk factors in postmenopausal women
8. Risk of venous thromboembolism in users of hormone replacement therapy
9. Estrogen replacement therapy and the risk of venous thrombosis
10. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism
11. Estrogen therapy in postmenopausal women: Effect on cognitive function and dementia
12. Hormone replacement therapy and the risk of colorectal cancer: A meta-analysis
13. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
14. Menopause-related oral alveolar bone resorption: A review of relatively unexplored consequence of estrogen deficiency
15. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy: Long-term follow-up of a Swedish cohort
16. Breast cancer and hormone replacement therapy: Collaborative re-analysis of data from 51 epidemiologic studies of 51,705 women with breast cancer and 108,411 women without breast cancer
17. Hormone replacement therapy and risk of breast cancer with a favorable histology: Result of Iowa Women's Health Study
18. Selective estrogen receptor modulators: Women's panacea for the next millennium
19. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
20. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the More randomized trial